Chemistry of Materials
Article
Compound 10. Red powder (100 mg, 80%). IR: 1605, 1724, 2228,
114.5, 114.6, 114.7, 118.2, 119.0, 119.1, 120.4, 120.8, 121.4, 122.7, 127.1,
127.2, 127.8, 128.4, 128.5, 129.0, 129.2, 129.4, 129.9, 130.1, 131.2, 131.3,
132.3, 132.4, 132.7, 132.8, 133.4, 134.2, 134.3, 136.8, 137.8, 140.0, 145.0,
150.7, 151.7, 152.4, 160.5, 163.2, 163.8, 164.2, 164.6, 164.9, 165.0, 165.9,
168.0, 168.3. MALDI-TOF (m/z, %): 3606.2 (M+, 100). Anal. Calcd for
C219H219BN8O37·H2O: C, 73.39; H, 6.22; N, 3.13. Found: C, 73.09; H,
6.45; N, 3.25.
Compound 15. Blue powder (148 mg, 41%). IR: 1602, 1725, 2232,
2858, 2929, 3330 cm−1. 1H NMR: δ 1.34 (m, 52H), 1.46 (m, 32H), 1.79
(m, 24H), 3.20 (s, 6H), 3.52 (m, 14H), 3.86 (s, 6H), 4.03 (m, 26H),
4.17 (s, 6H), 4.35 (m, 32H), 6.61 (s, 2H), 6.96 (d, J = 8.9 Hz, 24H), 7.12
(d, J = 16.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 24H), 7.45 (d, J = 8.1 Hz, 3H),
7.62 (d, J = 8.6 Hz, 22H), 7.70 (ABq, J = 7.6 Hz, 32H), 7.91 (d, J = 8.1
Hz, 6H), 8.12 (m, 32H), 8.40 (s, 6H), 8.63 (s, 5H), 8.98 (s, 3H). 13C
NMR: δ 14.9, 25.9, 26.0, 28.7, 29.1, 29.3, 29.4, 29.5, 29.5, 55.4, 58.8,
59.5, 65.5, 65.9, 68.2, 68.4, 71.6, 111.0, 114.4, 114.5, 114.6, 118.0, 118.9,
119.0, 121.2, 122.6, 127.0, 127.1, 127.7, 128.4, 128.5, 128.8, 129.3, 129.6,
129.9, 130.0, 130.9, 131.1, 132.4, 132.4, 132.7, 134.2, 136.7, 139.9, 144.9,
150.5, 151.0, 151.6, 152.2, 160.4, 162.9, 163.0, 163.7, 164.8, 164.9, 165.9,
167.8, 168.1. Anal. Calcd for C371H359BN12O65·H2O: C, 73.60; H, 6.01;
N, 2.78. Found: C, 73.53; H, 5.25; N, 2.54.
1
2852, 2924, 3322 cm−1. H NMR: δ 1.26−1.53 (m, 42H), 1.71−1.87
(m, 12H), 2.73 (s, 6H), 3.36 (s, 6H), 3.50−3.58 (m, 4H), 3.61−3.70 (m,
4H), 3.76 (s, 4H), 3.80−4.09 (m, 8H), 4.20 (s, 4H), 4.29−4.40 (m, 6H),
6.00 (s, 2H), 6.96 (d, J = 8.7 Hz, 6H), 7.31 (d, J = 8.7 Hz, 4H), 7.40 (d, J
= 8.3 Hz, 2H), 7.56−7.76 (m, 12H), 7.88 (d, J = 8.3 Hz, 2H), 7.93 (d, J =
8.3 Hz, 2H), 8.05 (d, J = 1.5 Hz, 2H), 8.14−8.17 (m, 8H), 8.59 (t, J = 1.5
Hz, 1H). 13C NMR: δ 14.8, 16.1, 26.0, 28.7, 29.1, 29.2, 29.3, 29.4, 29.5,
30.9, 41.2, 41.3, 58.9, 59.7, 65.5, 65.8, 68.4, 68.6, 71.8, 90.9, 111.0, 114.4,
114.5, 118.9, 120.8, 121.2, 121.8, 122.6, 127.2, 127.3, 127.7, 127.9, 128.3,
128.8, 129.2, 129.8, 132.3, 132.4, 132.7, 133.2, 134.3, 136.7, 137.8, 139.1,
140.3, 140.8, 144.9, 151.2, 151.7, 155.6, 163.8, 163.9, 164.6, 164.9, 165.1,
165.9, 167.8, 167.9. MALDI-TOF (m/z, %): 2114.4 (M+, 100). Anal.
Calcd for C127H137BN6O21·H2O: C, 72.21; H, 6.63; N, 3.98. Found: C,
72.32; H, 6.98; N, 4.12.
Compound 11. Red powder (156 mg, 78%). IR: 1604, 1727, 2227,
1
2854, 2924, 3322 cm−1. H NMR: δ 1.24−1.47 (m, 66H), 1.77−1.85
(m, 20H), 2.73 (s, 6H), 3.35 (s, 6H), 3.50−3.56 (m, 4H), 3.62−3.69 (m,
4H), 3.73 (s, 4H), 3.98−4.06 (m, 12H), 4.19 (s, 4H), 4.29−4.40 (m,
12H), 5.99 (s, 2H), 6.95 (d, J = 8.7 Hz, 10H), 7.29 (d, J = 8.3 Hz, 8H),
7.36 (d, J = 7.9 Hz, 2H), 7.57−7.74 (m, 24H), 7.88 (d, J = 8.3 Hz, 2H),
7.94 (d, J = 8.3 Hz, 2H), 8.04−8.19 (m, 14H), 8.35 (d, J = 1.5 Hz, 2H),
8.63 (t, J = 1.5 Hz, 2H), 8.93 (t, J = 1.5 Hz, 1H). 13C NMR: δ 14.8, 16.2,
26.0, 26.1, 28.7, 29.2, 29.3, 29.4, 29.5, 29.6, 31.0, 41.2, 41.4, 59.0, 59.7,
65.6, 65.9, 68.4, 68.7, 71.8, 91.0, 111.1, 114.5, 114.7, 118.9, 120.4, 121.3,
121.8, 122.6, 127.1, 127.2, 127.7, 127.9, 128.4, 128.5, 128.8, 129.1, 129.2,
129.9, 133.2, 134.2, 136.7, 137.8, 139.2, 140.2, 140.8, 144.9, 150.7, 151.7,
151.8, 155.7, 163.1, 163.8, 164.2, 164.5, 164.8, 164.9, 165.9, 167.9, 168.1.
MALDI-TOF (m/z, %): 3370.0 (M+, 100). Anal. Calcd for
C203H207BN8O35·H2O: C, 73.83; H, 6.29; N, 3.35. Found: C, 72.54;
H, 6.61; N, 3.40.
ASSOCIATED CONTENT
* Supporting Information
■
S
Techniques, instruments, and analytical data of the new
compounds. This material is available free of charge via the
AUTHOR INFORMATION
Corresponding Authors
■
Compound 12. Red powder (185 mg, 53%). IR: 1606, 1725, 2230,
2850, 2936, 3331 cm−1. 1H NMR: δ 1.32 (m, 80H), 1.78 (m, 40H), 2.73
(s, 6H), 3.36 (s, 6H), 3.54 (m, 4H), 3.66 (m, 4H), 3.74 (s, 4H), 4.03 (m,
22H), 4.20 (s, 6H), 4.37 (m, 20H), 6.00 (s, 2H), 6.96 (d, J = 8.9 Hz,
18H), 6.98 (d, J = 8.1 Hz, 3H), 7.28 (d, J = 8.6 Hz, 18H), 7.38 (d, J = 8.1
Hz, 3H), 7.61 (d, J = 8.6 Hz, 20H), 7.70 (ABq, J = 7.6 Hz, 38H), 7.92 (d,
J = 8.1 Hz, 6H), 8.13 (m, 33H), 8.41 (s, 6H), 8.64 (s, 5H), 8.98 (s, 3H).
13C NMR: δ 14.8, 16.1, 25.9, 26.0, 28.7, 29.2, 29.3, 29.4, 29.5, 29.6, 59.0,
59.7, 65.9, 68.4, 68.6, 71.8, 111.0, 114.4, 114.6, 118.9, 121.2, 121.8,
122.6, 127.0, 127.2, 127.7, 127.8, 128.4, 128.5, 128.8, 129.2, 129.8, 131.4,
132.4, 132.7, 136.7, 140.8, 140.8, 150.5, 150.6, 155.6, 162.9, 163.7, 164.2,
164.4, 164.8, 164.9, 165.9, 167.8, 168.1. MALDI-TOF (m/z, %): 5816.2
(M+, 100). Anal. Calcd for C355H347BN12O63·H2O: C, 73.28; H, 6.05; N,
2.89. Found: C, 73.69; H, 6.51; N, 3.15.
Present Address
‡S.M. is currently at Bio-Organic Division, Bhabha Atomic
Research Centre, Mumbai 400085, India
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
R.D. thanks the Swiss National Science Foundation (Grants
200020-140298 and 200020-152716) for financial support. J.B.
thanks the MINECO, Spain, for financial support under the
project CTQ2012-35692, which included FEDER funding. We
Compound 13. Blue powder (71 mg, 51%). IR: 1601, 1722, 2226,
1
2854, 2925, 3301 cm−1. H NMR: δ 1.28−1.49 (m, 42H), 1.72−1.84
(m, 12H), 3.13−3.20 (m, 12H), 3.49−3.55 (m, 4H), 3.72 (s, 4H), 3.85
(s, 6H), 3.99−4.08 (m, 6H), 4.16 (s, 4H), 4.29−4.39 (m, 6H), 6.59 (s,
2H), 6.93−7.00 (m, 10H), 7.10 (d, J = 16.2 Hz, 2H), 7.30 (d, J = 8.3 Hz,
4H), 7.40 (d, J = 7.9 Hz, 2H), 7.56−7.75 (m, 16H), 7.89 (d, J = 8.3 Hz,
2H), 7.94 (d, J = 8.3 Hz, 2H), 8.03−8.17(m, 12H), 8.59 (t, J = 1.5 Hz,
1H). 13C NMR: δ 15.1, 26.1, 28.8, 29.2, 29.3, 29.4, 29.5, 29.6, 41.3, 41.5,
55.5, 58.9, 59.5, 65.6, 65.9, 68.4, 68.5, 71.6, 91.7, 111.1, 114.5, 114.6,
118.2, 119.0, 119.1, 120.9, 121.4, 122.7, 127.2, 127.4, 127.8, 128.0, 128.4,
129.0, 129.4, 129.9, 130.1, 131.2, 132.4, 132.5, 132.6, 132.8, 133.4, 134.3,
136.8, 137.0, 137.8, 139.5, 140.0, 151.2, 151.7, 152.3, 160.5, 163.8, 164.0,
164.7, 164.9, 165.2, 166.0, 167.9. MALDI-TOF (m/z, %): 2350.7 (M+,
100). Anal. Calcd for C143H149BN6O23·H2O: C, 73.13; H, 6.48; N, 3.58.
Found: C, 73.29; H, 6.41; N, 3.65.
acknowledge the CNRS and the Minister
̀
e de l′Enseignement
Superieur de la Recherche for providing research facilities and
́
some financial support. S.M. is very grateful to the French
Embassy in India for the award of a Sandwich-PhD scholarship
and to the Bhabha Atomic Research Center for permission to
conduct research in France. We also thank Delphine Hablot and
Dr. Jean-Hubert Olivier for providing Bodipy Starting materials.
REFERENCES
■
(1) (a) Hosomizu, K.; Imahori, H.; Hahn, U.; Nierengarten, J.-F.;
Listorti, A.; Armaroli, N.; Nemoto, T.; Isoda, S. J. Phys. Chem. C 2007,
111, 2777−2786. (b) Lin, B. F.; Marullo, R. S.; Robb, M. J.; Krogstad, D.
V.; Antoni, P.; Hawker, C. J.; Campos, L. M.; Tirrell, M. V. Nano Lett.
2011, 11, 3946−3950. (c) Tomalia, D. A. New. J. Chem. 2012, 36, 264−
281. (d) Mignani, S.; Majoral, J.-P. New J. Chem. 2013, 37, 3337−3357.
(2) Tekade, R. K.; Kumar, P. V.; Jain, N. K. Chem. Rev. 2009, 109, 49−
87.
Compound 14. Blue powder (108 mg, 50%). IR: 1604, 1727, 2227,
1
2854, 2924, 3322 cm−1. H NMR: δ 1.24−1.51 (m, 66H), 1.72−1.86
(m, 24H), 3.14−3.20 (m, 10H), 3.50−3.54 (m, 4H), 3.75 (s, 4H), 3.85
(s, 6H), 3.98−4.06 (m, 10H), 4.16 (s, 4H), 4.28−4.40 (m, 10H), 6.60 (s,
2H), 6.93−7.01 (m, 12H), 7.10 (d, J = 16.2 Hz, 2H), 7.29 (d, J = 8.5 Hz,
8H), 7.40 (d, J = 8.1 Hz, 2H), 7.56−7.74 (m, 30H), 7.89 (d, J = 8.5 Hz,
2H), 7.95 (d, J = 8.1 Hz, 2H), 8.05−8.23 (m, 16H), 8.35 (d, J = 1.3 Hz,
2H), 8.63 (t, J = 1.3 Hz, 2H), 8.93 (t, J = 1.3 Hz, 1H). 13C NMR: δ 15.1,
26.0, 26.1, 28.8, 29.2, 29.3, 29.3, 29.4, 29.5, 29.6, 31.0, 41.2, 41.5, 55.5,
58.9, 59.5, 65.6, 66.0, 68.3, 68.4, 68.5, 68.6, 71.6, 91.0, 111.0, 111.1,
(3) Percec, V.; Leowanawat, P.; Sun, H.-J.; Kulikov, O.; Nusbaum, C.
D.; Tran, T. M.; Bertin, A.; Wilson, D. A.; Peterca, M.; Zhang, S.; Karnat,
N. P.; Vargo, K.; Moock, D.; Johnston, E. D.; Hammer, D. A.; Pochan, D.
́
J.; Chen, Y.; Chabre, Y. M.; Shiao, T. C.; Bergeron-Brlek, M.; Andre, S.;
I
Chem. Mater. XXXX, XXX, XXX−XXX